Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

OMNi-BiOTiC® Stress Release Awarded Probiotic of the Year by NutraIngredients USA

High-Performance Evidence-Based Psychobiotic Promotes Stress Response, Mood, Focus and Cognitive Function

Omni-Biotic Probiotics Logo

News provided by

Omni-Biotic Probiotics; AllergoSan USA

Aug 03, 2021, 10:50 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Aug. 3, 2021 /PRNewswire/ --  Omni-Biotic Stress Release is named "Product of the Year" in the probiotic category at the NutraIngredients USA Awards 2021. Focusing on innovation, long-term market success and cutting-edge research, the NutraIngredients USA Awards honor the best in ingredients, finished products, companies and initiatives in the nutrition and dietary supplements industry.

Continue Reading
Omni-Biotic Stress Release Probiotic
Omni-Biotic Stress Release Probiotic
NutraIngredients USA Awards 2021 Probiotic of the Year Logo
NutraIngredients USA Awards 2021 Probiotic of the Year Logo
Omni-Biotic Powder vs Capsule Brand Effectiveness Chart
Omni-Biotic Powder vs Capsule Brand Effectiveness Chart

Editor-in-Chief of NutraIngredients USA, Stephen Daniels (PhD), commented: "The judges were impressed by Omni-Biotic's science: Multiple clinical trials performed using the exact formula present in the product, and the focus on stress management, which is seen as being ahead of the potential next wave of probiotics positioned for stress, cognition, and focus. This is a well-formulated product supported by solid science."

CEO of Allergosan USA, Klaus Kleinfeld, adds: "It's an honor to have Omni-Biotic Stress Release recognized as the Probiotic of the Year. We are gratified that the judges recognize our commitment to science, clinical evidence, efficacy, and the importance of indication-specific probiotics. Omni-Biotic is well established in Europe. We are thrilled to be awarded as best-in-class in the U.S., and look forward to elevating Omni-Biotic's visibility to many more healthcare providers and patients." 

The company's gut-brain axis formulation, Omni-Biotic Stress Release, is a nine-strain psychobiotic designed to strengthen intestinal barrier integrity, and stimulate short chain fatty acids, anti-inflammatory cytokines and neurotransmitters, as well as degrade microbial toxins. Studied in controlled clinical trials, the supplementation of Omni-Biotic Stress Release showed improved mood, memory, cognition, stress response, and gastro-intestinal comfort†. This probiotic's unique delivery mechanism ensures a high effectiveness. 

Additional Omni-Biotic probiotics include formulations targeted at immune support, liver health, gut microbiome restoration, as well as prenatal and infant care.  

About Allergosan USA
Allergosan USA is the joint-venture partner of the globally recognized center for microbiome science, Institut Allergosan. In 2019, Allergosan USA introduced the leading, professional European probiotic brand Omni-Biotic to the U.S. The company is dedicated to delivering targeted probiotic blends for specific indications including stress, immunity, liver detox and more. Grounded in extensive research, testing and controlled clinical studies, Allergosan has a deep understanding of individual probiotic strain significance and how Omni-Biotic strains perform synergistically for specific health outcomes. The company is driven by the belief that a foundational element of wellness is a healthy digestive system. Their mission is to help people achieve optimal health by restoring and maintaining a healthy gut microbiome. In an effort to do more good, for every product purchased, Allergosan USA makes a donation to Feeding America, the largest hunger relief organization in the U.S.

About Omni-Biotic: Targeted Clinically Tested Probiotic Formulations
Multispecies & Multistrain Indication Focused Formulations: Each Omni-Biotic probiotic is a multistrain and multispecies formulation. Every strain is identified and extensively analyzed to determine strengths and suitability for its specific indication-focused formulation. All strains used in our products have FDA GRAS status.

Final Formulations Validated in Clinical Studies: Each Omni-Biotic formulation is validated through preclinical studies and controlled human trials. More than 50 studies using Omni-Biotic are published in high-ranked peer-reviewed journals such as AP&T and the American Journal of Gastroenterology.

Highly Effective Delivery Mechanism: Omni-Biotic probiotics have a much higher survival rate through the digestive tract, compared to capsule brands. Our powder contains freeze-dried bacteria (for extra shelf life) and prebiotic nutrients (as food for the probiotic bacteria). When Omni-Biotic is dissolved in water, the good bacteria rehydrate and nourish on the prebiotic nutrients. This makes the probiotics strong for the passage through the acidic environment of the stomach and small intestine. 85% of probiotic bacteria arrive in the large intestine alive, compared to less than 5% in many probiotic capsules.

Formulated by Gut Microbiome Experts: All Omni-Biotic formulations are developed by Institut Allergosan, an internationally recognized center for microbiome science and research. Founded in 1991 and headquartered in Austria, Institut Allergosan is dedicated to expanding the frontiers of microbiome research. They currently have more than 25 research partnerships with universities, including the Charite in Berlin. The Omni-Biotic product portfolio is highly awarded, including Winner "Best OTC performance" (IQVIA Austria Awards 2018), Winner "Quality Award" (IQVIA 2015, 2016 and 2017), and winner of "Europe's most innovative OTC product" (Nicholas Hall, 2016/2017).

Made for Performance & Convenience: Omni-Biotic comes as a powder, packaged in individual sachets. Each sachet is carefully designed to keep light and moisture out. The daily-dose sachets also make it convenient for travel and on-the-go. The probiotic bacteria in Omni-Biotic probiotics are freeze-dried and therefore do not require refrigeration. Their shelf life is generally 24 to 36 months, depending on the specific formulation.

To learn more, please visit:
www.omnibioticlife.com

For media and general inquiries, please contact:
Lena Kleinfeld
Director of Communications
[email protected]
914-615-9914

For healthcare professional and wholesale partnership inquiries, please contact:
Pam Conboy
Healthcare Practitioner Support & Education
[email protected] 
914-615-9914

SOURCE Omni-Biotic Probiotics; AllergoSan USA

Related Links

https://www.omnibioticlife.com/

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.